Literature DB >> 11879576

Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium.

David Roberts1, Stephen J Williams, Dusica Cvetkovic, Jillian K Weinstein, Andrew K Godwin, Steven W Johnson, Thomas C Hamilton.   

Abstract

We have developed a modified form of suppression subtractive hybridization (SSH) that allows multiple specimens of distinct phenotypic groups to be compared for consistent differences in gene expression. We applied this system to identify genes that were expressed in normal rat ovarian surface epithelial (ROSE) cells but whose expression was lost/downregulated in four independently transformed rat ovarian cancer cell lines. Northern blot analysis using 14 of 28 nonredundant cDNA fragments from this difference library showed that the mRNA transcripts were present in normal ROSE cells but lost or markedly downregulated in four related transformed cell lines. Of particular interest, cellular retinol-binding protein 1 (CRBP1) and retinol-binding protein (RBP), two genes whose products are involved in retinol transport and metabolism, were found to be downregulated in this ovarian cancer model system. To determine if this change had relevance to human ovarian cancer, we evaluated a series of human ovarian cancer cell lines and a limited number of frozen human ovarian tumors and found lost or decreased expression of CRBP1 and RBP relative to expression in human ovarian surface epithelial (HOSE) cells. We hypothesize that the loss of CRBP1 and RBP expression disrupts retinol metabolism and retinoic acid production, which may facilitate the occurrence of genetic damage leading to the malignant transformation of the ovarian surface epithelium, the cells from which ovarian cancer arises.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879576     DOI: 10.1089/10445490252810276

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  15 in total

1.  Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.

Authors:  Philipp Beckhove; Rolf Warta; Britt Lemke; Diana Stoycheva; Frank Momburg; Martina Schnölzer; Uwe Warnken; Hubertus Schmitz-Winnenthal; Rezvan Ahmadi; Gerhard Dyckhoff; Mariana Bucur; Simone Jünger; Thomas Schueler; Volker Lennerz; Thomas Woelfel; Andreas Unterberg; Christel Herold-Mende
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Construction and selection of subtracted cDNA library of mouse hepatocarcinoma cell lines with different lymphatic metastasis potential.

Authors:  Li Hou; Jan-Wu Tang; Xiao-Nan Cui; Bo Wang; Bo Song; Lei Sun
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 3.  Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases.

Authors:  Joseph L Napoli
Journal:  Pharmacol Ther       Date:  2017-01-27       Impact factor: 12.310

4.  Down-regulation of retinol binding protein 5 is associated with aggressive tumor features in hepatocellular carcinoma.

Authors:  Jenny C Y Ho; Siu Tim Cheung; Wing Sem Poon; Yuk Ting Lee; Irene O L Ng; Sheung Tat Fan
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-12       Impact factor: 4.553

Review 5.  Early events in ovarian oncogenesis.

Authors:  Dusica Cvetkovic
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

6.  Vitamin A metabolism is impaired in human ovarian cancer.

Authors:  Stephen J Williams; Dusica Cvetkovic; Thomas C Hamilton
Journal:  Gynecol Oncol       Date:  2008-12-25       Impact factor: 5.482

7.  Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells.

Authors:  Jing Li; Brandon Orr; Kayla White; Natalia Belogortseva; Richard Niles; Goran Boskovic; Hanh Nguyen; Ava Dykes; Maiyon Park
Journal:  Mol Cancer       Date:  2009-02-12       Impact factor: 27.401

8.  Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.

Authors:  Ben Davidson; Helene Tuft Stavnes; Arild Holth; Xu Chen; Yanqin Yang; Ie-Ming Shih; Tian-Li Wang
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

Review 9.  Animal models of ovarian cancer.

Authors:  Barbara C Vanderhyden; Tanya J Shaw; Jean-François Ethier
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

10.  Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer.

Authors:  Rajkumar S Kalra; Sharmila A Bapat
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.